- Article
- Published:
Possible Implication of Myristicin as a Psychotropic Substance
Naturevolume 210, pages380–384 (1966)Cite this article
469Accesses
4Altmetric
This is a preview of subscription content,access via your institution
Access options
Subscription info for Japanese customers
We have a dedicated website for our Japanese customers. Please go tonatureasia.com to subscribe to this journal.
Prices may be subject to local taxes which are calculated during checkout
References
Fluckiger, F. A.,Pharm. J. III,5, 136 (1874).
Semmler, F. W.,Ber.,23, 1803 (1890);24, 3819 (1891).
Thoms, H.,Ber.,36, 1714, 3446 (1903);41, 2753 (1908).
Trikojus, V. M., and White, D. E.,Nature,144, 1016 (1939).
Rao, K. V., Seshadri, T. R., and Thiruvengadam, T. R.,Proc. Indian Acad. Sci.,30A, 114 (1949).
Kafuku, K., and Ishikawa, N.,Bull. Indust. Res. Lab. Govt. of Formosa24, 27 (1928).
Schmidt, E., Schumacher, R., Bajen, W., and Wagner, A.,Ber.,55B, 1751 (1922).
Privett, O. S., Nadenicek, J. D., Weber, R. P., and Pusch, F. J.,J. Amer. Oil Chemists' Soc.,40, 28 (1963).
Truitt, jun., E. B., Duritz, G., and Ebersberger, E. M.,Proc. Soc. Exp. Biol. and Med.,112, 647 (1963).
Shulgrin, A. T.,Nature,197, 379 (1963).
Mitsuhishi, H., Muramatsu, T., Nagai, U., and Nishi, I.,Yagukaku Zasshi,79, 106 (1959).
Lichtenstein, E. P., and Casida, J. E.,Agric. and Food Chem.,11, 410 (1963).
Kurono, G., and Yamaguchi, I.,Ann. Rep. Fac. Pharm. Kanazawa Univ.,2, 1 (1952).
Fujita, Y.,J. Chem. Soc. Japan,62, 1014 (1941);63, 599 (1942).
Pickles, S. S.,J. Chem. Soc.,101, 1433 (1912).
Anet, E. F. L. J., Lythgoe, B., Silk, M. H., and Trippett, S.,J. Chem. Soc., 309 (1953).
Robineau, C.,Ann. Pharm. Franc.,11, 97 (1953).
Goodrich, F. J., and Lynn, E. V.,J. Amer. Pharm. Assoc.,17, 1096 (1928).
Maksyutina, N. P., and Kolesnikov, D. G.,Zhur. Obschei Khim.,29, 3836 (1959);31, 1386 (1961).
Itallie, L. v.,Pharm. Presse, Wiss.-prakt. Heft., 89 (1932);Bull. Acad. Med.,107, 278 (1932).
Shulgin, A. T.,Mind,1, 299 (1963).
Truitt, jun., E. B., Calloway, E., Braude, M. C., and Krantz, jun., J. C.,J. Neuropsychiat.,2, 205 (1961).
Truitt, jun., E. B., Duritz, G., and Ebersberger, E. M.,Proc. Soc. Exp. Biol. and Med.,112, 647 (1963).
Ciamiciam, G., and Silver, P.,Ber.,21, 1621 (1888).
Dandiya, P. C., and Menon, M. K.,J. Pharm. and Exp. Therap.,145, 42 (1964).
Shulgin, A. T.,Nature,201, 1120 (1964).
Merck D.R.P., 398, 011 see Beil (2),13, 526.
Kawabata, H.,J. Pharm. Soc. Japan,65, 9 (1945).
Moffett, R. B., Hanze, A. R., and Seay, P. H.,J. Med. Chem.,7, 178 (1964).
Bezecki, C., and Lange, J.,Roczniki Chem.,33, 703 (1959).
Sugasawa, S., and Kakemi, K.,J. Pharm. Soc. Japan,57, 172 (1937).
Author information
Authors and Affiliations
The Dow Chemical Co., Walnut Creek, California
ALEXANDER T. SHULGIN
- ALEXANDER T. SHULGIN
You can also search for this author inPubMed Google Scholar
Rights and permissions
About this article
Cite this article
SHULGIN, A. Possible Implication of Myristicin as a Psychotropic Substance.Nature210, 380–384 (1966). https://doi.org/10.1038/210380a0
Issue Date:
Share this article
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative